Low Bone Mass Panel by Massively Parallel Sequencing

Clinical Use

Use

The Low Bone Mass Panel is intended for patients with a clinical or suspected diagnosis of skeletal dysplasia characterized by low bone mass. The panel assesses 23 genes associated with conditions that lead to decreased bone mineral density, such as osteogenesis imperfecta. Patients may show a variety of symptoms including increased susceptibility to fractures, changes in bone structure, and other skeletal abnormalities. Disease inheritance can follow autosomal recessive, dominant, or X-linked patterns, reflecting the genetic complexity within the panel's targeted genes. The development of bone and cartilage can be significantly disrupted, necessitating genetic analysis for appropriate management and treatment strategies.

Special Instructions

This panel is designed for individuals suspected of having skeletal dysplasia. It is critical to consider family history and clinical symptoms in the evaluation process. For accurate results, samples should be handled according to provided instructions. Genetic counseling is advised post-testing to understand the implications of results. Individuals are advised to consult a healthcare provider if there are questions regarding symptoms or the testing process.

Limitations

The interpretation of genetic variants depends on current knowledge, which may evolve over time. There exist limitations in detection, such as potential diagnostic errors due to variant overlaps, rare variants not covered, sample mix-ups, and other factors. Genetic variants that do not contribute meaningfully to the phenotype may complicate associations, and conditions may be misdiagnosed. Genetic counseling is advised when uncertainties arise regarding results or inheritance patterns.

Test Details

New York Approved